Read-Gene Market Cap

Read-Gene has a market cap or net worth of 51.17 million as of April 24, 2025. Its market cap has decreased by -11.07% in one year.

Market Cap

51.17M

Enterprise Value

53.56M

Revenue

12.85M

Ranking

n/a

PE Ratio

n/a

Stock Price

4.34

Market Cap Chart

Since February 12, 2009, Read-Gene's market cap has increased from 31.83M to 51.17M, an increase of 60.74%. That is a compound annual growth rate of 2.97%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	51.17M	-12.50%
Dec 30, 2024	58.48M	-14.48%
Dec 29, 2023	68.38M	124.81%
Dec 30, 2022	30.42M	-8.19%
Dec 29, 2021	33.13M	8.08%
Dec 30, 2020	30.65M	293.94%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
NEUCA	3.12B
Synektik Spólka Akcyjna	1.74B
Voxel	1.50B
Celon Pharma	1.38B
Ryvu Therapeutics	749.09M
Selvita	583.70M
Bioceltix	573.21M
Centrum Medyczne ENEL-MED	551.47M

Market Cap Rankings